Cardiac Progenitor Cell Cycling Stimulated by Pim-1 Kinase

Rationale: Cardioprotective effects of Pim-1 kinase have been previously reported but the underlying mechanistic basis may involve a combination of cellular and molecular mechanisms that remain unresolved. The elucidation of the mechanistic basis for Pim-1 mediated cardioprotection provides important insights for designing therapeutic interventional strategies to treat heart disease. Objective: Effects of cardiac-specific Pim-1 kinase expression on the cardiac progenitor cell (CPC) population were examined to determine whether Pim-1 mediates beneficial effects through augmenting CPC activity. Methods and Results: Transgenic mice created with cardiac-specific Pim-1 overexpression (Pim-wt) exhibit enhanced Pim-1 expression in both cardiomyocytes and CPCs, both of which show increased proliferative activity assessed using 5-bromodeoxyuridine (BrdU), Ki-67, and c-Myc relative to nontransgenic controls. However, the total number of CPCs was not increased in the Pim-wt hearts during normal postnatal growth or after infarction challenge. These results suggest that Pim-1 overexpression leads to asymmetric division resulting in maintenance of the CPC population. Localization and quantitation of cell fate determinants Numb and &agr;-adaptin by confocal microscopy were used to assess frequency of asymmetric division in the CPC population. Polarization of Numb in mitotic phospho-histone positive cells demonstrates asymmetric division in 65% of the CPC population in hearts of Pim-wt mice versus 26% in nontransgenic hearts after infarction challenge. Similarly, Pim-wt hearts had fewer cells with uniform &agr;-adaptin staining indicative of symmetrically dividing CPCs, with 36% of the CPCs versus 73% in nontransgenic sections. Conclusions: These findings define a mechanistic basis for enhanced myocardial regeneration in transgenic mice overexpressing Pim-1 kinase.

[1]  Mark A Sussman,et al.  Cardiac stem cell genetic engineering using the alphaMHC promoter. , 2009, Regenerative medicine.

[2]  R. Bolli,et al.  Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells , 2009, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[3]  R. D. de Boer,et al.  Early Beneficial Effects of Bone Marrow‐Derived Mesenchymal Stem Cells Overexpressing Akt on Cardiac Metabolism After Myocardial Infarction , 2009, Stem cells.

[4]  M. Goumans,et al.  Cell therapy for myocardial regeneration. , 2009, Current molecular medicine.

[5]  T. McDonnell,et al.  The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death , 2009, Apoptosis.

[6]  M. Hesse,et al.  c-kit expression identifies cardiovascular precursors in the neonatal heart , 2009, Proceedings of the National Academy of Sciences.

[7]  G. Vereb,et al.  Die hard: Are cancer stem cells the Bruce Willises of tumor biology? , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[8]  M. Gnecchi,et al.  Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.

[9]  Joseph C. Wu Molecular imaging: antidote to cardiac stem cell controversy. , 2008, Journal of the American College of Cardiology.

[10]  Seppo Ylä-Herttuala,et al.  Overexpression of Vascular Endothelial Growth Factor-B in Mouse Heart Alters Cardiac Lipid Metabolism and Induces Myocardial Hypertrophy , 2008, Circulation research.

[11]  C. Bearzi,et al.  Cardiac stem cells and myocardial disease. , 2008, Journal of molecular and cellular cardiology.

[12]  S. Houser,et al.  Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload , 2008, Proceedings of the National Academy of Sciences.

[13]  Z. Wang,et al.  Pim kinase-dependent inhibition of c-Myc degradation , 2008, Oncogene.

[14]  Mark A Sussman,et al.  Activation of Notch-Mediated Protective Signaling in the Myocardium , 2008, Circulation research.

[15]  Mark A Sussman,et al.  Evolution of the c‐kit‐Positive Cell Response to Pathological Challenge in the Myocardium , 2008, Stem cells.

[16]  W. Zhong,et al.  Neurogenesis and asymmetric cell division , 2008, Current Opinion in Neurobiology.

[17]  J. Chang,et al.  Current Status and Issues in Cancer Stem Cell Study , 2008, Cancer investigation.

[18]  Jacques Corbeil,et al.  Bendamustine (Treanda) Displays a Distinct Pattern of Cytotoxicity and Unique Mechanistic Features Compared with Other Alkylating Agents , 2008, Clinical Cancer Research.

[19]  Kim-Anh Do,et al.  Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer , 2008, BMC Medical Genomics.

[20]  Marielle Afanassieff,et al.  Self‐Renewal of Murine Embryonic Stem Cells Is Supported by the Serine/Threonine Kinases Pim‐1 and Pim‐3 , 2007, Stem cells.

[21]  Mark A Sussman "AKT"ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation. , 2007, Trends in cardiovascular medicine.

[22]  N. Magnuson,et al.  Pim-1 Kinase-Dependent Phosphorylation of p21Cip1/WAF1 Regulates Its Stability and Cellular Localization in H1299 Cells , 2007, Molecular Cancer Research.

[23]  M. Steenman,et al.  The prokineticin receptor‐1 (GPR73) promotes cardiomyocyte survival and angiogenesis , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  Kui Liu,et al.  MEK1/2 Regulates Microtubule Organization, Spindle Pole Tethering and Asymmetric Division During Mouse Oocyte Meiotic Maturation , 2007, Cell cycle.

[25]  S. Houser,et al.  Pim-1 regulates cardiomyocyte survival downstream of Akt , 2006, Nature Medicine.

[26]  Anthony J. Muslin,et al.  Akt2 Regulates Cardiac Metabolism and Cardiomyocyte Survival* , 2006, Journal of Biological Chemistry.

[27]  I. Shiojima,et al.  Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure. , 2006, Physiological genomics.

[28]  Mark A Sussman,et al.  Akt Promotes Increased Cardiomyocyte Cycling and Expansion of the Cardiac Progenitor Cell Population , 2006, Circulation research.

[29]  Mark A Sussman,et al.  Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy , 2006, Proceedings of the National Academy of Sciences.

[30]  C. Bearzi,et al.  Stem cell niches in the adult mouse heart. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Anthony J. Muslin,et al.  Akt1 Is Required for Physiological Cardiac Growth , 2006, Circulation.

[32]  A. Rosenzweig,et al.  Effects of chronic Akt activation on glucose uptake in the heart. , 2006, American journal of physiology. Endocrinology and metabolism.

[33]  J. Ingwall,et al.  Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  P. Petersen,et al.  The Enigma of the Numb-Notch Relationship during Mammalian Embryogenesis , 2006, Developmental Neuroscience.

[35]  H. Schatten,et al.  Role of NuMA in vertebrate cells: review of an intriguing multifunctional protein. , 2006, Frontiers in bioscience : a journal and virtual library.

[36]  M. Beckerle,et al.  Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. , 2005, The Journal of clinical investigation.

[37]  P. Anversa,et al.  Cardiac stem cells and mechanisms of myocardial regeneration. , 2005, Physiological reviews.

[38]  D. Torella,et al.  Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Hammerman,et al.  Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. , 2005, Blood.

[40]  A. Levine,et al.  The p53 pathway: positive and negative feedback loops , 2005, Oncogene.

[41]  P. Meltzer,et al.  Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival. , 2005, Blood.

[42]  M. Soonpaa,et al.  Targeted Expression of Cyclin D2 Results in Cardiomyocyte DNA Synthesis and Infarct Regression in Transgenic Mice , 2004, Circulation research.

[43]  Y. Ahn,et al.  Nuclear Targeting of Akt Enhances Kinase Activity and Survival of Cardiomyocytes , 2003, Circulation research.

[44]  R. R. Brenner,et al.  Effect of different carbon sources on Δ5 desaturation activity of HTC cells , 1991, Molecular and Cellular Biochemistry.

[45]  S. Bishop,et al.  Transgenic animals as a tool for studying the effect of the c-myc proto-oncogene on cardiac development , 2004, Molecular and Cellular Biochemistry.

[46]  T. Sjöblom,et al.  Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. , 2003, The American journal of pathology.

[47]  L. Monassier,et al.  Overexpression of the Serotonin 5-HT2B Receptor in Heart Leads to Abnormal Mitochondrial Function and Cardiac Hypertrophy , 2003, Circulation.

[48]  Wenyi Wei,et al.  Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase. , 2002, Biochimica et biophysica acta.

[49]  J. Ross,et al.  Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[50]  S. Cook,et al.  Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart* , 2002, The Journal of Biological Chemistry.

[51]  N. Bhattacharya,et al.  Pim-1 associates with protein complexes necessary for mitosis , 2002, Chromosoma.

[52]  P. Anversa,et al.  bcl-2 overexpression promotes myocyte proliferation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Kang,et al.  Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice , 2002, Molecular and Cellular Biology.

[54]  R. Hajjar,et al.  Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo , 2001, Circulation.

[55]  C. Chresta,et al.  MDM2 mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells. , 2001, Molecular pharmacology.

[56]  R. Kitsis,et al.  Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. , 2000, Circulation.

[57]  A. Mui,et al.  STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells , 1999, The EMBO journal.

[58]  S. Leach,et al.  p21Waf1/Cip1 Inhibition of Cyclin E/Cdk2 Activity Prevents Endoreduplication after Mitotic Spindle Disruption , 1999, Molecular and Cellular Biology.

[59]  B. Li,et al.  Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[60]  H. Liang,et al.  Ubiquitous expression and cell cycle regulation of the protein kinase PIM-1. , 1996, Archives of biochemistry and biophysics.

[61]  P. Anversa,et al.  ANG II receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure. , 1993, The American journal of physiology.

[62]  I. Weissman,et al.  Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[63]  S. Bishop,et al.  The c-myc proto-oncogene regulates cardiac development in transgenic mice , 1990, Molecular and cellular biology.